July 13, 2026
Notice Regarding MolDX: Biomarker Testing for Risk Stratification in DCIS (DL40246)
Medicare Administrative Contractors (MACs) carefully considered all feedback received from interested parties regarding proposed Local Coverage Determination (LCD) DL40246: MolDX: Biomarker Testing for Risk Stratification in DCIS.
Given the impact of this determination, MACs will delay finalization of the proposed LCD issued on 7.17.2025. Additional information will be forthcoming in the following months.

